Abstract
Microarrays represent a modern powerful technology, which have potential applications in many areas of biological research and provide new insights into the genomics and transcriptomics of living systems. The aim of this review is to describe the application of microarray technology for Mycobacterium avium subsp. paratuberculosis (MAP) research. The main focus points include a summary of results obtained for MAP using microarrays, examination of the fields of MAP research which are currently being investigated and possible areas of future research. This article is divided into two parts according to the type of nucleic acid used for array hybridisation. Articles related to MAP research using microarray technology are then divided according to the field of study, such as comparative genome analysis, diagnostics, expression or environmental studies.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Mycobacterium Avium Subsp. Paratuberculosis
In general, mycobacteria are slender, non-spore-forming, rod-shaped and slow growing microorganisms. They belong to the family Mycobacteriaceae, whose characteristic feature is the presence of mycolic acids in the cell wall contributing to acid-fastness (often described as “acid-fast bacilli”). The distinguishing features of Mycobacterium avium subsp. paratuberculosis (MAP) include a long generation time, tight clump formation in liquid media and mycobactin dependence. MAP was first described in Germany in 1895 by Professor Heinrich Albert Johne and his assistant Langdon Frothingham, and was identified as the causal agent of a ruminant inflammatory disease, called paratuberculosis or also known as Johne’s disease [1]. It is described as chronic infectious enteritis affecting mainly domestic ruminants, such as cows, sheep and goats, but also in some cases other animal species including primates and humans. The disease is primarily located in the terminal ileum and colon and it is characterised by the depletion of health conditions, emaciation, decreased milk production and diarrhoea. Young animals are the most susceptible, nevertheless adult animals can be also infected, particularly in the case of higher doses of MAP or longer exposure [2–4].
Symptoms of paratuberculosis are similar to those of Crohn’s disease (CD), which is a human systematic disorder manifesting itself in the chronic inflammation of the gastrointestinal tract. As in paratuberculosis, mainly the terminal ileum and colon are affected and the disease is usually characterised by abdominal pain, general malaise, loss of energy and weight, and other non-specific symptoms [5, 6]. A definitive explanation of CD causation does not yet exist, although MAP is thought to be one of the triggering factors [5–10]. Drinking water, water aerosol [11], milk [12–15] or even meat [16] are considered to be sources of MAP in human populations.
The complete genome of MAP (Strain K10) has already been sequenced and deposited in the GenBank database (http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi). It comprises of a single circular chromosome of more than 4.8 × 106 base pairs, encoding 4,350 genes [17]. Compared to other mycobacteria (M. tuberculosis, M. leprae and M. bovis), the MAP genome is characterised by special characteristics which possibly play a role in its distinctive features. These include a higher number of regulatory genes, which may correlate with its ability to survive under diverse environmental conditions and increased redundancy in the genes connected with lipid metabolism, which probably result in a more robust cell wall structure and consequently the ability of MAP to colonise the intestine of ruminants [17, 18]. Although most of MAP genes have already been described, one-third of them remain to be functionally characterised. For more information about genomics of mycobacteria and MAP see reference [18].
Microarrays
Microarray (array, microchip, biochip, DNA chip or gene chip) technology represents an important tool for the investigation of various areas of biology, mainly due its ability to simultaneously detect and analyse thousands of different genes in a single experiment. Miniaturisation, speed and accuracy are the other attractive characteristics of this approach. Traditional arrays contain nucleic acid probes immobilised on the solid surface of a chip. These hybridise with added nucleic acid molecules (targets), which are fluorescently labelled, commonly with Cy3 and Cy5 dyes. The fluorescence signal is subsequently scanned and the resultant image is processed by image analysis and data analysis software [19–23].
Microarray technology is increasingly being applied to many fields such as diagnostics, genetic and mutation analysis, evolutionary and expression studies, and environmental research. Today, various types of microarrays are utilised for the analysis of different target material, such as DNA [24–26], cDNA [27, 28], RNA [29], PCR products [30], proteins [31–33] and other materials allowing quantitative analysis. Common types of microarrays include oligonuceotide arrays, cDNA arrays, protein and tissue arrays [20]. For mycobacteria research, two types of microarrays are most commonly used: (i) high-density oligonucleotide arrays; and (ii) spotted microarrays.
High-density oligonucleotide arrays are produced by synthesising oligonucleotides directly on a chip by a photolithographic chemical reaction. This technique allows the production of a high-density chip containing thousands of short probes (15–70 nucleotides) targeted at different loci in a certain genome. Its salient feature is the presence of two types of probes––perfect match probe and mismatch probe; the latter differs from the former by a single base in the middle of its sequence. The chip contains several different sequences from the same gene, and therefore can be used to identify different variants (alleles) of the selected gene [34]. The Affymetrix GeneChip represents the current leading in situ hybridised chip [35, 36].
The use of the spotted array involves the independent synthesis of probes and their consequent spotting on a slide using a microarray spotter. In comparison with a high-density array, each probe of spotted array corresponds exclusively to a single gene or transcript. Various single-stranded or dissociated double-stranded nucleic acids can be used as probes, dependent on the type of microarray (gDNA, cDNA, synthetic oligonucleotides, PCR products or restriction-enzyme digested fragments). The length of the probe is commonly between 200 and 800 nucleotides, but in a case of synthetic oligonucleotides it could be much shorter i.e., from 50 to 70 nucleotides. This technique is now used through out the world to produce home-made arrays for the analysis of different types of samples. Moreover, it allows customisation when the species origin and number of probes should be chosen with regard to the studied material. For more information about spotted and cDNA microarrays and their use, refer to the following reviews [37–39].
Whereas high-density oligonucleotide arrays are produced by commercial companies, spotted microarrays are commonly designed and prepared in research laboratories. However, to generate comparable and reproducible data, a spotted microarray platform has to fulfil various requirements. These include above all, appropriate experimental design, the presence of target molecules in sufficient quality and quantity, the design of probes, appropriate hybridisation conditions, the inclusion of a housekeeping gene in the case of expression studies, normalisation strategies or validation and data analysis. In particular, data mining and visualisation strategies are greatly important with regard to the huge amount of results generated by microarrays. For detailed information about the designing of microarray experiments and their evaluation see review articles [40–46].
Application of Microarray Technology in MAP
Microarray technology is becoming more and more used by various types of research laboratories. Commercial chips containing the genomes of important or common bacteria are widely available. Unfortunately at present there is not a single commercial chip available for MAP. However, a few arrays containing the whole MAP genome have been developed [47–49]. Microarrays can be classified from many perspectives; in this review, they are divided according to the type of the target nucleic acid and subdivided according to their practical application (Table 1).
Target Nucleic Acid: DNA
Diagnostics
The diagnosis of bacteria is based on commonly used techniques, such as microscopy, culture, biochemical tests or PCR diagnostics. Although these methods may be laborious, time consuming, expensive or not applicable in some cases, they still represent the “gold standard” for bacterial identification. Microarray analysis introduces a new direction in this field; nevertheless, their broad application is still limited by their higher price. However, in the case of clinical and food analysis, in which time is a critical factor, microarray technology can represent a suitable tool [50–52]. Another benefit of arrays is their ability to distinguish between closely related pathogens (subspecies or isolates), identify virulence factors or reveal variations within a pathogen’s genome. Such results can be then effectively used to identify drug resistance or find the best therapy [53–56]. The diagnostics of pathogens could be either surveyed using the species specific sequences or by expression patterns of certain gene sequences. While the first method is described in this section, the second one will be discussed in the chapter concerning RNA (cDNA) as an array target.
One of the first applications of a bacterial high-density DNA probe array was that developed for diagnostics of mycobacteria [53]. Discrimination among bacteria was based on 16S rDNA polymorphisms. While some minor discrepancies between phenotypic and genotypic identifications were observed, 26 out of 27 species were correctly identified. However, MAP and M. avium subsp. avium (MAA) were not identified individually because of having identical 16S regions on the array. According to the authors, this problem could be solved by lengthening the sequence region. Apart from the 16S rDNA region, the array also contained probes for the rpoB and katG region, which are responsible for rifampicin and isoniazid resistance, respectively [57, 58]. Using this array approach, single point mutations could be easily identified and thus clinical interpretation could be facilitated.
Tobler et al. [54] developed an identification method for mycobacteria based on the 65 kDa heat shock gene (also known as hsp65 or groEL2). Their system comprised of a two-step procedure involving real-time PCR detection followed by subsequent microarray hybridisation. In total, 37 different mycobacterial species were tested, including MAP. For closely related species (with 95–100% sequence homology), like MAP and MAA, only one probe was designed. In such a case, the same hybridisation pattern was observed all the time for both species, and thus they could not be distinguished from one another.
The diagnosis of mycobacteria in human medicine is mostly focused on M. tuberculosis complex or on different non-tuberculous mycobacteria (e.g. M. intracellulare, M. kansasii, M. gordonae and M. marinum) which can cause opportunist infections, mainly in immuno-suppressed people [55, 56]. Moreover, the high level of similarity among individual members within M. avium complex (MAC), especially between MAP and MAA makes diagnosis more difficult. For the above reasons, a few scientific articles concerned with the diagnostics of MAP using array technology have been published [56].
Comparative Genome Analysis
DNA microarrays represent a very powerful tool for comparative genomic studies. Their contribution in this area lies in the acquisition of useful information concerning subspecies or isolate discrimination, virulence factors identification, facilitating an understanding of host preferences and others, such as determination of disease markers. Hence, they can subsequently improve diagnostics or facilitate vaccine development. Although mycobacterial research is frequently focussed on the detection of genomic polymorphisms between MAA and MAP, other non-tuberculous species have also been investigated. DNA microarray technology helped to reveal large sequence polymorphisms (LSPs) which were either specifically presented in MAA and not in MAP, or vice versa [59–61]. In particular, two LSPs were revealed and their presence in various MAA and MAP isolates was confirmed as present or absent. Even though most of the identified LSPs lacked the sensitivity and specificity necessary for the diagnosis of MAP infection, the authors assumed that they could serve as infection or disease markers [61].
The finding of LSPs was confirmed by Wu et al. [62], who defined these areas as genomic islands (GIs). Using microarrays they found 24 and 18 GIs specific for MAA and MAP, respectively. They described two types of genomic rearrangements (i) inversions, possibly responsible for the regulation of significant antigen expression and (ii) insertions or deletions of GIs which could be important for pathogen survival in different environments. Interestingly, most Gl deletions were discovered in MAP isolates originating from wild life animals, suggesting that these animals can represent a potential source of genomic rearrangements in MAP. Moreover, an in-depth analysis of GIs among MAA and MAP isolates revealed a higher level of plasticity for MAA isolates as a result of their higher polymorphism rate, when compared with MAP.
Marsh et al. [47] focussed their attention on genetic variability among various isolates of one species; they compared MAP strains isolated from one sheep and two cattle isolates. Three large genomic deletions were found in the sheep isolate when compared to the cattle strains. Unfortunately, the functions of most of the missing genes are not known and therefore the effect of their absence or presence is unclear. Although the study was limited by using an array based only on a cattle strain genome, these results could help clarify differences and features of MAP strains originating from different hosts.
Afterwards, the deletions in sheep strains were confirmed by Paustian et al. [49], who identified the missing LSPs as the regions involved in various functions such as lipid and energy metabolism, virulence and transcriptional metabolism. Moreover, regions in sheep isolates, which were not present in cattle isolates, were discovered. These regions encode proteins involved in glycopeptidolipid biosynthesis, transcriptional regulation and virulence. According to the authors, they could contribute to phenotypic differences between sheep and cattle isolates. MAP genomes from various isolates (cattle, birds, goats, bison and human) had a hybridisation profile similar to the reference MAP Strain K10 (a cattle genomotype). In any of the cattle genomotype isolates, no LSPs were found contrary to other studied mycobacterial isolates (MAA, MAH and MAS), which also served as references. This could imply either a wide distribution of cattle genomotype isolates of MAP in the environment or their higher capability of infecting various hosts [49].
The study of MAP genetic variability has revealed some important features, which may be important for understanding MAP behaviour, its divergence from other mycobacteria, or the production of certain proteins, which could be useful for diagnostic purposes. This approach was implemented on various MAP strains used to produce Johnin PPDs (purified protein derivates) in different laboratories [63]. It is known that large sequences presented in MAA are missing in MAP strains and vice versa [62]. In a study by Semret et al. [63], large genomic sequences responsible for Johnin PPD production were determined as missing in some MAP strains. According to authors, this absence could occur as a consequence of continuous in vitro passages, which could lead to the inability of the strain to synthesise the Johnin protein and/or to poor sensitivity of the Johnin reagents.
Environmental Studies
Research into microbial ecology uses several types of microarrays, mostly divided according to their applied targets [64]. Environmental arrays play an important role in the study of the relationships among bacteria from various environments [65], identification of new functional genes, metagenomic studies [66] or for the determination of genomic relatedness using comparative genomic analysis [56].
According to our information, no metagenomic or general environmental study concerning MAP has been carried out using microarray technology. A comparative approach using a whole-genome array was used by Marsh et al. [47] who compared MAP strains from sheep and cattle, by Wu et al. [62] who studied the genomic diversity of MAP isolated from humans, domesticated and wildlife animals, as well as by Semret et al. [63], who characterised MAP strains used for the production of PPDs. All these articles are described in detail in section 'Comparative Genome Analysis' of this review.
Target Nucleic Acid: RNA (cDNA)
Gene expression analysis is based on the assumption that cells react to changes in their environment by increasing or decreasing transcription of appropriate genes. These changes in expression levels can be detected or quantified by specific methods such as Northern blotting [67], S1 nuclease protection [68], sequencing of cDNA libraries [69] or serial analysis of gene expression––SAGE [70]. Today, these methods have been replaced by real-time reverse transcription-PCR (real-time RT-PCR) and microarray technology. Real-time RT-PCR represents an extremely sensitive, rapid and easy method for the precise determination and quantification of gene expression. Compared to real-time RT-PCR, microarrays represent a semi-quantitative rather than quantitative method, although their biggest advantage lies in reliable screening of huge amount of genes simultaneously in one experiment. Currently, real-time PCR and microarrays represent the most powerful techniques for expression profiling studies [71–74].
Most of the published MAP gene expression studies are concerned with paratuberculosis, although a few have been published for CD. These can be divided according to either the host response to MAP or directly according to the gene expression of MAP itself. To our knowledge, only one article relating to gene expression of MAP and its response to environment and stress factors has so far been published [48].
Wu et al. [48] subjected MAP to a temperature of 45°C, under acidic and oxidative stress to induce general stress and mimic the environment in abomasums or within macrophages, respectively. The array containing all of the MAPs predicted open reading frames (ORFs) which identified a set of genes with the same transcriptional pattern within all stress conditions. Most of the genes were induced under acidic pH, which could be connected with conditions in enteric macrophages and could highlight the importance of a change in pH for MAP pathogenesis. As expected by the authors, the experiments revealed the up-regulation of various sigma factors. Based on the data obtained, sigH was suggested to be involved in oxidative and heat stress, sigD and sigG in persistent infection, and sigI in adaptation to cold shock. These results are similar as those described for M. tuberculosis, where sigH was induced after heat and oxidative shock and sigI after mild cold shock [75, 76]. Not many studies have been carried out in this area until now; therefore additional research will be needed in order to understand the mechanisms of the MAP response to various conditions and its survival in such environments.
Paratuberculosis––Gene Expression Analysis of Host Cells
Paratuberculosis is commonly diagnosed by cultivation of faecal samples and light microscopy, a PCR method using IS900 [77–79] and F57 sequence [80] or by the detection of antibodies using the ELISA method [81]. In vitro measurement of cell-mediated immune responses based on measurement of released gamma interferon (IFN-γ) offers the possibility to identify animals with sub-clinical paratuberculosis infection [82]. Compared to the above approaches, microarrays allow the detection of any phase of paratuberculosis, and moreover, they enable the study of gene expression profiles, which could provide information on the origin or behaviour of the disease.
All expression studies carried out on animal or human cell lines infected by MAP are based on the assumption that MAP infection alters the expression profile of host cells. For this reason different cell lines are exposed to mycobacteria and subsequently the level of their gene expression can be studied using microarrays. Due to the fact that macrophages play a fundamental role in the immune response to intracellular pathogens and MAP preferentially dwell within macrophages, many research groups use these types of cells for expression research (see review citation [83] for more information regarding macrophages and microarrays and citation [84–86] for macrophages and mycobacteria). Expression profiles of immune system host cells are mainly determined for cells infected by mycobacteria either in vitro or naturally.
Microarrays have been used frequently in the work of Coussens et al. [87–89] who employed them to observe the gene expression in peripheral blood mononuclear cells (PBMCs) after MAP infection. In 2002, Coussens et al. [87] found differences in gene expression profiles when comparing cows in clinical and sub-clinical phases of infection. Surprisingly, many genes were found to be repressed in cells from animals in the clinical phase, while activated in the case of animals in the sub-clinical phase. Although these results brought interesting informations, the authors themselves pointed out the low number of tested samples, which could limit the validity of their conclusions. Later they were able to confirm the differences in gene expression in host cells of infected and uninfected animals. They also showed that the common response to stimulation by MAP is generally manifested by gene down-regulation in host immune cells [88]. Coussens et al. [89] then affirmed their previous results concerning the different expression profiles in PBMCs infected by MAP and in control cells. Moreover, they showed an enhanced expression of transforming growth factor-β (TGF-β) and tissue inhibitors of matrix metalloproteinases (TIMPs) whose enhanced expression could lead to tissue migration deficiency of the infected PBMCs. Finally, it was shown that MAP-infected PBMCs were highly pro-apoptotic as they were expressing genes involved in apoptosis at higher levels than control cells.
Aho et al. [27] also studied gene expression, but in contrast to previous articles they aimed their attention at tissues from paratuberculosis positive and negative cows. Two genes coding for tumour necrosis factor receptor-associated protein 1 (TRAF1) and interleukin-1α (IL-1α), were found to be dramatically over-expressed in positive animals. Because TRAF1 is known to have an anti-apoptotic role, its increased expression could explain, according to the authors, macrophage accumulation in lesions associated with paratuberculosis. The over-expression of IL-1 and the subsequent toxicity of its protein could be connected with paratuberculosis symptoms.
It is known that bovine macrophages are able to kill MAA in vitro, but do not have the ability to kill MAP [90]. A comparison of macrophage expression response to MAA and MAP infection can therefore provide new information about the survival strategies of MAP and the defence mechanisms of host organism. Weiss et al. [91] tried to solve this problem using bovine microarrays and found out a decreased ability of MAP-infected macrophages to undergo acidification, although the expression of their vacuolar H+ ATPase was higher compared to those infected with MAA. As the major function of H+ ATPase is related to phagosome acidification, the authors assumed this could contribute to the inability of MAP-infected macrophages to be acidified. It was also demonstrated that some genes of MAP-infected macrophages were differentially expressed in different time intervals which could be connected with the inability of the macrophages to maintain the dynamic immune response against MAP.
Subsequently, Weiss et al. [92] used a human array to characterise the response of MAP-infected macrophages in comparison with unactivated macrophages and macrophages activated by incubation with MAA, IFN-γ or lipopolysaccharide. Lower expression of major histocompatibility (MHC) antigen class II molecule in cells infected with MAP in comparison with unactivated cells, represented the most interesting observation. Low MHC II expression logically leads to the decreased capacity of affected macrophages to present antigens, and in the long term to a diminished immune response of the host organism. In general, many genes with various functions were differentially expressed, which gives evidence of complex interactions between macrophages and the attacking organism [92].
The work of Murphy et al. [93] had a similar focus to that of Weiss et al. [91, 92]. Similarly to Weiss et al., Murphy et al. [93] observed an increased expression of vacuolar H+ ATPase in MAP-infected macrophages. However, they observed similar expression profiles in most macrophages infected with MAA or MAP, even when some significant changes in expression were observed. Most of the differentially expressed genes belonged to or were somehow connected with three MAPK (mitogen-activated protein kinase) pathways (p38, ERK1/2 or JNK). Although MAPK pathways genes were rapidly activated in both MAA- and MAP-infected macrophages, the level of expression was considerably lower in the latter. The differences in the MAPK pathway gene expressions could be related to the observed stronger induction of gene expression in macrophages infected with MAA than with MAP.
The presence of mycobacteria has been previously described in mammary glands and milk [94, 95]. Patel et al. [96] later demonstrated the ability of MAP to enter, survive and to persist within the bovine mammary epithelial cells (MAC-T) and subsequently their invasion into Madin–Darby bovine kidney epithelial cells (MDBK). MAP incubated in milk was more invasive for MDBK, when compared with MAP exposed to water or a broth environment. These results showed that an environment of high osmolarity could serve as a trigger for the expression of determinants connected with the MAP invasion of host cells. Patel et al. [96] used microarrays for obtaining detailed information about gene expression of MAP isolated from infected MAC-T cells. From the bulk of genes, 20 (mainly regulatory, metabolic or virulence connected genes) were strongly induced. Nevertheless, the precise functions of those genes are still unknown; further research is required in this field.
Paratuberculosis––Gene Expression Analysis of MAP
Gene expression can not only provide useful information for the investigation of cellular responses to stress conditions or for the study of host immune system reactions to infection, but can also be used as a diagnostic tool.
The expression of genes can exhibit a specific expression signature, which may be unique for a particular disease caused by a pathogen. As paratuberculosis is characterised by a long sub-clinical phase, such signature identification could be very useful for the determination of the infection phase [97]. CD30L seems to be a potentially interesting candidate gene which can contribute to an expression signature specific for sub-clinical paratuberculosis. The use of microarrays and real-time RT-PCR identified CD30L and the gene encoding P-selectin to be differentially expressed in leucocytes originating from infected cattle when compared with controls. CD30L is a cytokine belonging to the tumour necrosis factor family regulating cell activation, proliferation and apoptosis. P-selectin, a membrane glycoprotein, serves as an adhesion receptor for leucocytes. Considering that P-selectin represents an important marker for other diseases and thus it is not specific for paratuberculosis, CD30L seems to be as a more suitable candidate [97].
Crohn’s Disease––Gene Expression Analysis of Host Cells
Microarrays are beginning to play an important role in clinical investigation directed at the discovery of biomarkers. They allow the analysis of thousands of biomarkers from relatively a few patients, compared to common models which require hundreds of patients for statistical validation of a single marker [98]. Whether or not MAP could constitute as a trigger for CD is yet to be confirmed. Although the isolation of living bacteria from human patients is very difficult, viable MAPs have been isolated from various tissues of Crohn’s patients, including peripheral blood or human breast milk [6, 7, 9, 95]. However, the onset of disease as a result of an autoimmune response to MAP represents another possibility for CD etiology (for more information about MAP and CD see references [99–101]. The study of host–pathogen interactions and the response of host immune system can provide new evidence of MAP association with CD occurrence, and microarrays, in particular, can widely contribute to this.
In general, expression profiles of host immune cells infected by MAP originating either from paratuberculosis-infected animals or from Crohn′s patients, are mostly studied on animal cell lines (see section 'Paratuberculosis––Gene Expression Analysis of Host Cells'). Human cell lines are rarely used. To date, only Motiwala et al. [102] have used transformed human cells lines challenged by MAP infection and assessed the level of their gene expression using the MAP K10 microarray.
Motiwala et al. [102] examined transcriptional changes in the expression profiles of human monocytes after phagocytosis using MAP strains from CD patients, cattle and sheep. A shared global expression pattern of anti-inflammatory pathways for human and cattle isolates based on their anti-invasive entry into macrophages was shown. This was in contrast with sheep isolates, whose pro-inflammatory genes were strongly induced. Anti-inflammatory pathways in human and cattle isolates could be associated with an effective infection process and persistence, whereas pro-inflammatory processes in sheep isolates can indicate host adaptation, evolution and rarity in other hosts. The results of this study indicate the importance of the MAP genotype to host specificity.
Conclusion
The most useful and employed applications of microarrays in MAP research are genomic and expression studies, although relatively few papers dealing with environmental or diagnostics aspects have been published. Genomic studies using microarray technology have revealed significant differences between MAP and MAA genomes, mainly manifested as gene deletions. These results have a great impact on the understanding of the pathogenic potential of MAP, its virulence and host specificity.
Expression studies have become increasingly popular mostly due to the invention of microarrays and their implementation into practice. In MAP research, microarrays have been mainly used to ascertain the gene expression of infected host immune cells. Numerous studies have examined the up- and down- regulation of genes in MAP infected cells, in comparison with control (uninfected) cells or with cells infected with MAA. Research into the MAP response to stress conditions, and its survival in the environment, offers another field for the wide usage of microarrays. Expression studies can be utilised to elucidate the defence mechanisms of the host cells against MAP infection and determine MAP survival strategies allowing them to be used not only in veterinary, but also in human medicine. Although microarrays have already contributed significantly to paratuberculosis research, there are still many unresolved questions which need to be answered.
Abbreviations
- CD:
-
Crohn’s disease
- cDNA:
-
Complementary deoxyribonucleic acid
- gDNA:
-
Genomic deoxyribonucleic acid
- GIs:
-
Genomic islands
- ELISA:
-
Enzyme linked immunosorbent assay
- IFN-γ:
-
Gamma interferon
- IL-1α:
-
Interleukin-1α
- LSPs:
-
Large sequence polymorphisms
- MAA :
-
Mycobacterium avium subsp. avium
- MAC :
-
Mycobacterium avium complex
- MAC-T:
-
Mammary epithelial cells
- MAH :
-
Mycobacterium avium subsp. hominissuis
- MAP :
-
Mycobacterium avium subsp. paratuberculosis
- MAS :
-
Mycobacterium avium subsp. silvaticum
- MAPK pathways:
-
Mitogen-activated protein kinase
- MDBK:
-
Madin–Darby bovine kidney epithelial cells
- MHC class II:
-
Major histocompatability class II
- ORFs:
-
Open reading frames
- PBMCs:
-
Peripheral blood mononuclear cells
- PPD:
-
Purified protein derivates
- real-time RT-PCR:
-
Real-time reverse transcription PCR
- SAGE:
-
Serial analysis of gene expression
- TGFβ:
-
Transforming growth factor-β
- TIMPs:
-
Tissue inhibitors of matrix metalloproteinases
- TRAF1:
-
Tumor necrosis factor receptor-associated protein 1
References
Johne, H. A., & Frothingham, L. (1895). Ein eigenthümlicher fall von tuberculose beim rind. Deutsche Zeitschrift fur Tiermedicin und Pathologie, 21, 438–454.
Manning, E. J., & Collins, M. T. (2001). Mycobacterium avium subsp. paratuberculosis: Pathogen, pathogenesis and diagnosis. Review of Science and Technology OIE, 20, 133–150.
Hermon-Taylor, J., & El-Zaatari, F. A. K. (2004). The Mycobacterium avium subspecies paratuberculosis problem and its relation to the causation of Crohn disease. In S. Pedley, J. Bartram, G. Rees, A. Dufour, & J. A. Cotruvo (Eds.), Pathogenic mycobacteria water: A guide to public health consequences, monitoring, management (pp. 74–94). London, UK: IWA Publishing.
Grant, I. R. (2005). Zoonotic potential of Mycobacterium avium ssp paratuberculosis: The current position. Journal of Applied Microbiology, 98, 1282–1293. doi:10.1111/j.1365-2672.2005.02598.x.
Hermon-Taylor, J., & Bull, T. (2002). Crohn’s disease caused by Mycobacterium avium subspecies paratuberculosis: A public health tragedy whose resolution is long overdue. Journal of Medical Microbiology, 51, 3–6.
Bull, T. J., McMinn, E. J., Sidi-Boumedine, K., Skull, A., Durkin, D., Neild, P., et al. (2003). Detection and verification of Mycobacterium avium subsp paratuberculosis (MAP) in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn’s disease. Journal of Clinical Microbiology, 41, 2915–2923. doi:10.1128/JCM.41.7.2915-2923.2003.
Naser, S. A., Ghobrial, G., Romero, C., & Valentine, J. F. (2004). Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn’s disease. Lancet, 364, 1039–1044. doi:10.1016/S0140-6736(04)17058-X.
Cheng, J., Bull, T. J., Dalton, P., Cen, S., Finlayson, C., & Hermon-Taylor, J. (2005). Mycobacterium avium subspecies paratuberculosis in the inflamed gut tissues of patients with Crohn’s disease in China and its potential relationship to the consumption of cow’s milk: A preliminary study. World Journal of Microbiology & Biotechnology, 21, 1175–1179. doi:10.1007/s11274-005-0809-z.
Sechi, L. A., Scanu, A. M., Molicotti, P., Cannas, S., Mura, M., Dettori, G., et al. (2005). Detection and isolation of Mycobacterium avium subspecies paratuberculosis from intestinal mucosal biopsies of patients with and without Crohn’s disease in Sardinia. The American Journal of Gastroenterology, 100, 1529–1536. doi:10.1111/j.1572-0241.2005.41415.x.
Nakase, H., Nishio, A., Tamaki, H., Matsuura, M., Asada, M., Chiba, T., et al. (2006). Specific antibodies against recombinant protein of insertion element 900 of Mycobacterium avium subspecies paratuberculosis in Japanese patients with Crohn’s disease. Inflammatory Bowel Diseases, 12, 62–69. doi:10.1097/01.MIB.0000191671.12229.47.
Hermon-Taylor, J., Bull, T. J., Sheridan, J. M., Cheng, J., Stellakis, M. L., & Sumar, N. (2000). Causation of Crohn’s disease by Mycobacterium avium subspecies paratuberculosis. Canadian Journal of Gastroenterology, 14, 521–539.
Grant, I. R., Ball, H. J., & Rowe, M. T. (1999). Effect of higher pasteurization temperatures, and longer holding times at 72 degrees C, on the inactivation of Mycobacterium paratuberculosis in milk. Letters in Applied Microbiology, 28, 461–465. doi:10.1046/j.1365-2672.1999.00557.x.
Grant, I. R., O’Riordan, L. M., Ball, H. J., & Rowe, M. T. (2001). Incidence of Mycobacterium paratuberculosis in raw sheep and goats’ milk in England, Wales and Northern Ireland. Veterinary Microbiology, 79, 123–131. doi:10.1016/S0378-1135(00)00344-8.
Grant, I. R., Hitchings, E. I., McCartney, A., Ferguson, F., & Rowe, M. T. (2002). Effect of commercial-scale high-temperature, short-time pasteurization on the viability of Mycobacterium paratuberculosis in naturally infected cows’ milk. Applied and Environmental Microbiology, 68, 602–607. doi:10.1128/AEM.68.2.602-607.2002.
Slana, I., Kralik, P., Kralova, A., & Pavlik, I. (2008). On-farm spread of Mycobacterium avium subsp. paratuberculosis in raw milk studied by IS900 and F57 competitive real time quantitative PCR and culture examination. International Journal of Food Microbiology, 128, 250–257. doi:10.1016/j.ijfoodmicro.2008.08.013.
Abubakar, I., Myhill, D. J., Hart, A. R., Lake, I. R., Harvey, I., Rhodes, J. M., et al. (2007). A case-control study of drinking water and dairy products in Crohn’s disease––further investigation of the possible role of Mycobacterium avium paratuberculosis. American Journal of Epidemiology, 165, 776–783. doi:10.1093/aje/kwk067.
Li, L.L., Bannantine, J.P., Zhang, Q., Amonsin, A., May, B.J., Alt, D., et al. (2005). The complete genome sequence of Mycobacterium avium subspecies paratuberculosis. Proceedings of the National Academy of Sciences of the United States of America, 102, 12344–12349. doi:10.1073/pnas.0505662102.
Marri, P. R., Bannantine, J. P., & Golding, G. B. (2006). Comparative genomics of metabolic pathways in Mycobacterium species: Gene duplication, gene decay and lateral gene transfer. FEMS Microbiology Reviews, 30, 906–925. doi:10.1111/j.1574-6976.2006.00041.x.
Gabig, M., & Wegrzyn, G. (2001). An introduction to DNA chips: Principles, technology, applications and analysis. Acta Biochimica Polonica, 48, 615–622.
Chaudhuri, J. D. (2005). Genes arrayed out for you: The amazing world of microarrays. Medical Science Monitor, 11, RA52–RA62.
Kumar, A., Goel, G., Fehrenbach, E., Puniya, A. K., & Singh, K. (2005). Microarrays: The technology, analysis and application. Engineering in Life Sciences, 5, 215–222. doi:10.1002/elsc.200420075.
Ehrenreich, A. (2006). DNA microarray technology for the microbiologist: An overview. Applied Microbiology and Biotechnology, 73, 255–273. doi:10.1007/s00253-006-0584-2.
Jaluria, P., Konstantopoulos, K., Betenbaugh, M., & Shiloach, J. (2007). A perspective on microarrays: Current applications, pitfalls, and potential uses. Microbial Cell Factories, 6, Article 4 (1–14). doi:10.1186/1475-2859-6-4.
Behr, M. A., Wilson, M. A., Gill, W. P., Salamon, H., Schoolnik, G. K., Rane, S., et al. (1999). Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science, 28, 1520–1523. doi:10.1126/science.284.5419.1520.
Cho, J. C., & Tiedje, J. M. (2002). Quantitative detection of microbial genes by using DNA microarrays. Applied and Environmental Microbiology, 68, 1425–1430. doi:10.1128/AEM.68.3.1425-1430.2002.
Harriff, M. J., Wu, M., Kent, M. L., & Bermudez, L. E. (2008). Species of environmental mycobacteria differ in their abilities to grow in human, mouse, and carp macrophages and with regard to the presence of mycobacterial virulence genes, as observed by DNA microarray hybridization. Applied and Environmental Microbiology, 74, 275–285. doi:10.1128/AEM.01480-07.
Aho, A. D., McNulty, A. M., & Coussens, P. M. (2003). Enhanced expression of interleukin-1alpha and tumor necrosis factor receptor-associated protein 1 in ileal tissues of cattle infected with Mycobacterium avium subsp. paratuberculosis. Infection and Immunity, 71, 6479–6486. doi:10.1128/IAI.71.11.6479-6486.2003.
McGarvey, J. A., Wagner, D., & Bermudez, L. E. (2004). Differential gene expression in mononuclear phagocytes infected with pathogenic and non-pathogenic mycobacteria. Clinical and Experimental Immunology, 136, 490–500. doi:10.1111/j.1365-2249.2004.02490.x.
Rosenow, C., Saxena, R. M., Durst, M., & Gingeras, T. R. (2001). Prokaryotic RNA preparation methods useful for high density array analysis: Comparison of two approaches. Nucleic Acids Research, 29, Article e112 (1–8).
Diaz, R., Siddiqi, N., & Rubin, E. J. (2006). Detecting genetic variability among different Mycobacterium tuberculosis strains using DNA microarrays technology. Tuberculosis (Edinburgh, Scotland), 86, 314–318. doi:10.1016/j.tube.2006.01.002.
Templin, M. F., Stoll, D., Schrenk, M., Traub, P. C., Vohringer, C. F., & Joos, T. O. (2002). Protein microarray technology. Drug Discovery Today, 7, 815–822. doi:10.1016/S1359-6446(00)01910-2.
Bannantine, J. P., Waters, W. R., Stabel, J. R., Palmer, M. V., Li, L. L., Kapur, V., et al. (2008a). Development and use of a partial Mycobacterium avium subspecies paratuberculosis protein array. Proteomics, 8, 463–474. doi:10.1002/pmic.200700644.
Bannantine, J. P., Bayles, D. O., Waters, W. R., Palmer, M. V., Stabel, J. R., & Paustian, M. L. (2008b). Early antibody response against Mycobacterium avium subspecies paratuberculosis antigens in subclinical cattle. Proteome Science, 6, Article 5 (1–12). doi:10.1186/1477-5956-6-5.
Lipshutz, R. J., Fodor, S. P. A., Gingeras, T. R., & Lockhart, D. J. (1999). High density synthetic oligonucleotide arrays. Nature Genetics, 21, 20–24. doi:10.1038/4447.
Dalma-Weiszhausz, D. D., Warrington, J., Tanimoto, E. Y., & Miyada, C. G. (2006). The affymetrix GeneChip platform: An overview. In R. A. Kimmel & B. Oliver (Eds.), Methods in Enzymology, vol. 410: DNA microarrays part A: Array platforms, wet-bench protocols (pp. 3–28). San DiegoUSA: Elsevier Academic Press Inc.
Fu, L. M. (2006). Exploring drug action on Mycobacterium tuberculosis using affymetrix oligonucleotide genechips. Tuberculosis (Edinburgh, Scotland), 86, 134–143. doi:10.1016/j.tube.2005.07.004.
Hegde, P., Qi, R., Abernathy, K., Gay, C., Dharap, S., Gaspard, R., et al. (2000). A concise guide to cDNA microarray analysis. BioTechniques, 29, 548–562.
Xiang, C. C., & Chen, Y. D. (2000). cDNA microarray technology and its applications. Biotechnology Advances, 18, 35–46. doi:10.1016/S0734-9750(99)00035-X.
Leung, Y. F., & Cavalieri, D. (2003). Fundamentals of cDNA microarray data analysis. Trends in Genetics, 19, 649–659. doi:10.1016/j.tig.2003.09.015.
Brazma, A., Hingamp, P., Quackenbush, J., Sherlock, G., Spellman, P., Stoeckert, C., et al. (2001). Minimum information about a microarray experiment (MIAME)—toward standards for microarray data. Nature Genetics, 29, 365–371. doi:10.1038/ng1201-365.
Relogio, A., Schwager, C., Richter, A., Ansorge, W., & Valcarcel, J. (2002). Optimization of oligonucleotide-based DNA microarrays. Nucleic Acids Research, 30, Article e51 (1–10).
Benes, V., & Muckenthaler, M. (2003). Standardization of protocols in cDNA microarray analysis. Trends in Biochemical Sciences, 28, 244–249. doi:10.1016/S0968-0004(03)00068-9.
Dheda, K., Huggett, J. F., Bustin, S. A., Johnson, M. A., Rook, G., & Zumla, A. (2004). Validation of housekeeping genes for normalizing RNA expression in real-time PCR. BioTechniques, 37, 112–119.
Korn, E. L., Habermann, J. K., Upender, M. B., Ried, T., & McShane, L. M. (2004). Objective method of comparing DNA microarray image analysis systems. BioTechniques, 36, 960–967.
Yauk, C. L., & Berndt, M. L. (2007). Review of the literature examining the correlation among DNA microarray technologies. Environmental and Molecular Mutagenesis, 48, 380–394. doi:10.1002/em.20290.
Zhang, L. S., Kujis, J. N., & Liu, X. H. (2008). Information visualization for DNA microarray data analysis: A critical review. IEEE Transactions on Systems Man and Cybernetics Part C, 38, 42–54.
Marsh, I. B., Bannantine, J. P., Paustian, M. L., Tizard, M. L., Kapur, V., & Whittington, R. J. (2006). Genomic comparison of Mycobacterium avium subsp paratuberculosis sheep and cattle strains by microarray hybridization. Journal of Bacteriology, 188, 2290–2293. doi:10.1128/JB.188.6.2290-2293.2006.
Wu, C. W., Schmoller, S. K., Shin, S. J., & Talaat, A. M. (2007). Defining the stressome of Mycobacterium avium subsp paratuberculosis in vitro and in naturally infected cows. Journal of Bacteriology, 189, 7877–7886. doi:10.1128/JB.00780-07.
Paustian, M. L., Zhu, X., Sreevatsan, S., Robbe-Austerman, S., Kapur, V., & Bannantine, J. P. (2008). Comparative genomic analysis of Mycobacterium avium subspecies obtained from multiple host species. BMC Genomics, 20, Article 135 (1–15). doi:10.1186/1471-2164-9-135.
Bodrossy, L., & Sessitsch, A. (2004). Oligonucleotide microarrays in microbial diagnostics. Current Opinion in Microbiology, 7, 245–254. doi:10.1016/j.mib.2004.04.005.
Call, D. R. (2005). Challenges and opportunities for pathogen detection using DNA microarrays. Critical Reviews in Microbiology, 31, 91–99. doi:10.1080/10408410590921736.
Ojha, S., & Kostrzynska, M. (2008). Examination of animal and zoonotic pathogens using microarrays. Veterinary Research, 39, Article 4 (1–22). doi:10.1051/vetres:2007042.
Troesch, A., Nguyen, H., Miyada, C. G., Desvarenne, S., Gingeras, T. R., Kaplan, P. M., et al. (1999). Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays. Journal of Clinical Microbiology, 37, 49–55.
Tobler, N. E., Pfunder, M., Herzog, K., Frey, J. E., & Altwegg, M. (2006). Rapid detection and species identification of Mycobacterium spp. using real-time PCR and DNA Microarray. Journal of Microbiological Methods, 66, 116–124. doi:10.1016/j.mimet.2005.10.016.
Fukushima, M., Kakinuma, K., Hayashi, H., Nagai, H., Ito, K., & Kawaguchi, R. (2003). Detection and identification of Mycobacterium species isolates by DNA microarray. Journal of Clinical Microbiology, 41, 2605–2615. doi:10.1128/JCM.41.6.2605-2615.2003.
Park, H., Jang, H. J., Song, E., Chang, C. L., Lee, M., Jeong, S., et al. (2005). Detection and genotyping of Mycobacterium species from clinical isolates and specimens by oligonucleotide array. Journal of Clinical Microbiology, 43, 1782–1788. doi:10.1128/JCM.43.4.1782-1788.2005.
Heym, B., Zhang, Y., Poulet, S., Young, D., & Cole, S. T. (1993). Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis. Journal of Bacteriology, 175, 4255–4259.
Telenti, A., Imboden, P., Marchesi, F., Lowrie, D., Cole, S., Colston, M. J., et al. (1993). Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet, 341, 647–650. doi:10.1016/0140-6736(93)90417-F.
Semret, M., Zhai, G., Mostowy, S., Cleto, C., Alexander, D., Cangelosi, G., et al. (2004). Extensive genomic polymorphism within Mycobacterium avium. Journal of Bacteriology, 186, 6332–6334. doi:10.1128/JB.186.18.6332-6334.2004.
Paustian, M. L., Kapur, V., & Bannantine, J. P. (2005). Comparative genomic hybridizations reveal genetic regions within the Mycobacterium avium complex that are divergent from Mycobacterium avium subsp. paratuberculosis isolates. Journal of Bacteriology, 187, 2406–2415. doi:10.1128/JB.187.7.2406-2415.2005.
Semret, M., Alexander, D. C., Turenne, C. Y., de Haas, P., Overduin, P., van Soolingen, D., et al. (2005). Genomic polymorphisms for Mycobacterium avium subsp. paratuberculosis diagnostics. Journal of Clinical Microbiology, 43, 3704–3712. doi:10.1128/JCM.43.8.3704-3712.2005.
Wu, C. W., Glasner, J., Collins, M., Naser, S., & Talaat, A. M. (2006). Whole-genome plasticity among Mycobacterium avium subspecies: Insights from comparative genomic hybridizations. Journal of Bacteriology, 188, 711–723. doi:10.1128/JB.188.2.711-723.2006.
Semret, M., Bakker, D., Smart, N., Olsen, I., Haslov, K., & Behr, M. A. (2006). Genetic analysis of Mycobacterium avium complex strains used for producing purified protein derivatives. Clinical and Vaccine Immunology; CVI, 13, 991–996. doi:10.1128/CVI.00217-06.
Gentry, T. J., Wickham, G. S., Schadt, C. W., He, Z., & Zhou, J. (2006). Microarray applications in microbial ecology research. Microbial Ecology, 52, 159–175. doi:10.1007/s00248-006-9072-6.
Kostic, T., Weilharter, A., Rubino, S., Delogu, G., Uzzau, S., Rudi, K., et al. (2007). A microbial diagnostic microarray technique for the sensitive detection and identification of pathogenic bacteria in a background of nonpathogens. Analytical Biochemistry, 360, 244–254. doi:10.1016/j.ab.2006.09.026.
Sebat, J. L., Colwell, F. S., & Crawford, R. L. (2003). Metagenomic profiling: Microarray analysis of an environmental genomic library. Applied and Environmental Microbiology, 69, 4927–4934. doi:10.1128/AEM.69.8.4927-4934.2003.
Alwine, J.C., Kemp, D.J., & Stark, G.R. (1977). Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proceedings of the National Academy of Sciences of the United States of America, 74, 5350–5354. doi:10.1073/pnas.74.12.5350.
Berk, A. J., & Sharp, P. A. (1977). Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids. Cell, 12, 721–732. doi:10.1016/0092-8674(77)90272-0.
Okubo, K., Hori, N., Matoba, R., Niiyama, T., Fukushima, A., Kojima, Y., et al. (1992). Large scale cDNA sequencing for analysis of quantitative and qualitative aspects of gene expression. Nature Genetics, 2, 173–179. doi:10.1038/ng1192-173.
Velculescu, V. E., Zhang, L., Vogelstein, B., & Kinzler, K. W. (1995). Serial analysis of gene expression. Science, 270, 484–487. doi:10.1126/science.270.5235.484.
King, H. C., & Sinha, A. A. (2001). Gene expression profile analysis by DNA microarrays—Promise and pitfalls. Journal of the American Medical Association, 286, 2280–2288. doi:10.1001/jama.286.18.2280.
Xiang, Z. Y., Yang, Y. N., Ma, X. J., & Ding, W. (2003). Microarray expression profiling: Analysis and applications. Current Opinion in Drug Discovery, 6, 384–395.
Sharkey, F. H., Banat, I. M., & Marchant, R. (2004). Detection and quantification of gene expression in environmental bacteriology. Applied and Environmental Microbiology, 70, 3795–3806. doi:10.1128/AEM.70.7.3795-3806.2004.
Dallas, P. B., Gottardo, N. G., Firth, M. J., Beesley, A. H., Hoffmann, K., Terry, P. A., Freitas, J. R., Boag, J. M., Cummings, A. J., & Kees, U. R. (2005). Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR—how well do they correlate? BMC Genomics, 6, Article 59 (1–10). doi:10.1186/1471-2164-6-59.
Manganelli, R., Dubnau, E., Tyagi, S., Kramer, F. R., & Smith, I. (1999). Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis. Molecular Microbiology, 31, 715–724. doi:10.1046/j.1365-2958.1999.01212.x.
Manganelli, R., Provvedi, R., Rodrigue, S., Beaucher, J., Gaudreau, L., & Smith, I. (2004). Sigma factors and global gene regulation in Mycobacterium tuberculosis. Journal of Bacteriology, 186, 895–902. doi:10.1128/JB.186.4.895-902.2004.
Vary, P. H., Andersen, P. R., Green, E., Hermon-Taylor, J., & McFadden, J. J. (1990). Use of highly specific DNA probes and the polymerase chain reaction to detect Mycobacterium paratuberculosis in Johne’s disease. Journal of Clinical Microbiology, 28, 933–937.
Bartos, M., Hlozek, P., Svastova, P., Dvorska, L., Bull, T., Matlova, L., et al. (2006). Identification of members of Mycobacterium avium species by Accu-Probes, serotyping, and single IS900, IS901, IS1245 and IS901-flanking region PCR with internal standards. Journal of Microbiological Methods, 64, 333–345. doi:10.1016/j.mimet.2005.05.009.
Bhide, M., Chakurkar, E., Tkacikova, L., Barbuddhe, S., Novak, M., & Mikula, I. (2006). IS900-PCR-based detection and characterization of Mycobacterium avium subsp paratuberculosis from buffy coat of cattle and sheep. Veterinary Microbiology, 112, 33–41. doi:10.1016/j.vetmic.2005.10.004.
Vansnick, E., De Rijk, P., Vercammen, F., Geysen, D., Rigouts, L., & Portaels, F. (2004). Newly developed primers for the detection of Mycobacterium avium subspecies paratuberculosis. Veterinary Microbiology, 100, 197–204. doi:10.1016/j.vetmic.2004.02.006.
Speer, C. A., Scott, M. C., Bannantine, J. P., Waters, W. R., Mori, Y., Whitlock, R. H., et al. (2006). A novel enzyme-linked immunosorbent assay for diagnosis of Mycobacterium avium subsp. paratuberculosis infections (Johne’s disease) in cattle. Clinical and Vaccine Immunology; CVI, 13, 535–540. doi:10.1128/CVI.13.5.535-540.2006.
Jungersen, G., Huda, A., Hansen, J. J., & Lind, P. (2002). Interpretation of the gamma interferon test for diagnosis of subclinical paratuberculosis in cattle. Clinical and Diagnostic Laboratory Immunology, 9, 453–460. doi:10.1128/CDLI.9.2.453-460.2002.
McGuire, K., & Glass, E. J. (2005). The expanding role of microarrays in the investigation of macrophage responses to pathogens. Veterinary Immunology and Immunopathology, 105, 259–275. doi:10.1016/j.vetimm.2005.02.001.
Gomes, M. S., Paul, S., Moreira, A. L., Appelberg, R., Rabinovitch, M., & Kaplan, G. (1999). Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles of murine macrophages. Infection and Immunity, 67, 3199–3206.
Nguyen, L., & Pieters, J. (2005). The Trojan horse: Survival tactics of pathogenic mycobacteria in macrophages. Trends in Cell Biology, 15, 269–276. doi:10.1016/j.tcb.2005.03.009.
Woo, S. R., & Czuprynski, C. J. (2008). Tactics of Mycobacterium avium subsp. paratuberculosis for intracellular survival in mononuclear phagocytes. Journal of Veterinary Science (Suwon-si, Korea), 9, 1–8.
Coussens, P. M., Colvin, C. J., Wiersma, K., Abouzied, A., & Sipkovsky, S. (2002). Gene expression profiling of peripheral blood mononuclear cells from cattle infected with Mycobacterium paratuberculosis. Infection and Immunity, 70, 5494–5502. doi:10.1128/IAI.70.10.5494-5502.2002.
Coussens, P. M., Colvin, C. J., Rosa, G. J. M., Laspiur, J. P., & Elftman, M. D. (2003). Evidence for a novel gene expression program in peripheral blood mononuclear cells from Mycobacterium avium subsp paratuberculosis-infected cattle. Infection and Immunity, 71, 6487–6498. doi:10.1128/IAI.71.11.6487-6498.2003.
Coussens, P. M., Pudrith, C. B., Skovgaard, K., Ren, X. N., Suchyta, S. P., Stabel, J. R., et al. (2005). Johne’s disease in cattle is associated with enhanced expression of genes encoding IL-5, GATA-3, tissue inhibitors of matrix metalloproteinases 1 and 2, and factors promoting apoptosis in peripheral blood mononuclear cells. Veterinary Immunology and Immunopathology, 105, 221–234. doi:10.1016/j.vetimm.2005.02.009.
Weiss, D. J., Evanson, O. A., Moritz, A., Deng, M. Q., & Abrahamsen, M. S. (2002). Differential responses of bovine macrophages to Mycobacterium avium subsp paratuberculosis and Mycobacterium avium subsp avium. Infection and Immunity, 70, 5556–5561. doi:10.1128/IAI.70.10.5556-5561.2002.
Weiss, D. J., Evanson, O. A., Deng, M. Q., & Abrahamsen, M. S. (2004). Sequential patterns of gene expression by bovine monocyte-derived macrophages associated with ingestion of mycobacterial organisms. Microbial Pathogenesis, 37, 215–224. doi:10.1016/j.micpath.2004.07.001.
Weiss, D. J., Evanson, O. A., Deng, M., & Abrahamsen, M. S. (2004). Gene expression and antimicrobial activity of bovine macrophages in response to Mycobacterium avium subsp. paratuberculosis. Veterinary Pathology, 41, 326–337. doi:10.1354/vp.41-4-326.
Murphy, J. T., Sommer, S., Kabara, E. A., Verman, N., Kuelbs, M. A., Saama, P., et al. (2006). Gene expression profiling of monocyte-derived macrophages following infection with Mycobacterium avium subspecies avium and Mycobacterium avium subspecies paratuberculosis. Physiological Genomics, 28, 67–75. doi:10.1152/physiolgenomics.00098.2006.
Streeter, R. N., Hoffsis, G. F., Bechnielsen, S., Shulaw, W. P., & Rings, M. (1995). Isolation of Mycobacterium paratuberculosis from colostrum and milk of subclinically infected cows. American Journal of Veterinary Research, 56, 1322–1324.
Naser, S. A., Schwartz, D., & Shafran, I. (2000). Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn’s disease patients. The American Journal of Gastroenterology, 95, 1094–1095. doi:10.1111/j.1572-0241.2000.01954.x.
Patel, D., Danelishvili, L., Yamazaki, Y., Alonso, M., Paustian, M. L., Bannantine, J. P., et al. (2006). The ability of Mycobacterium avium subsp paratuberculosis to enter bovine epithelial cells is influenced by preexposure to a hyperosmolar environment and intracellular passage in bovine mammary epithelial cells. Infection and Immunity, 74, 2849–2855. doi:10.1128/IAI.74.5.2849-2855.2006.
Skovgaard, K., Grell, S. N., Heegaard, P. M. H., Jungersen, G., Pudrith, C. B., & Coussens, P. M. (2006). Differential expression of genes encoding CD30L and P-selectin in cattle with Johne’s disease: Progress toward a diagnostic gene expression signature. Veterinary Immunology and Immunopathology, 112, 210–224. doi:10.1016/j.vetimm.2006.02.006.
Csillag, C., Nielsen, O. H., Borup, R., & Nielsen, F. C. (2005). Microarrays and Crohn’s disease: Collecting reliable information. Scandinavian Journal of Gastroenterology, 40, 369–377. doi:10.1080/00365520510012226.
Chamberlin, W., Graham, D. Y., Hulten, K., El-Zimaity, H. M. T., Schwartz, M. R., Naser, S., et al. (2001). Review article: Mycobacterium avium subsp. paratuberculosis as one cause of Crohn’s disease. Alimentary Pharmacology & Therapeutics, 15, 337–346. doi:10.1046/j.1365-2036.2001.00933.x.
Uzoigwe, J. C., Khaitsa, M. L., & Gibbs, P. S. (2007). Epidemiological evidence for Mycobacterium avium subspecies paratuberculosis as a cause of Crohn’s disease. Epidemiology and Infection, 135, 1057–1068. doi:10.1017/S0950268807008448.
Behr, M. A., & Kapur, V. (2008). The evidence for Mycobacterium paratuberculosis in Crohn’s disease. Current Opinion in Gastroenterology, 24, 17–21.
Motiwala, A. S., Janagama, H. K., Paustian, M. L., Zhu, X. C., Bannantine, J. P., Kapur, V., et al. (2006). Comparative transcriptional analysis of human macrophages exposed to animal and human isolates of Mycobacterium avium subspecies paratuberculosis with diverse genotypes. Infection and Immunity, 74, 6046–6056. doi:10.1128/IAI.00326-06.
Acknowledgements
The authors would like to thank Maria Vass (Veterinary Research Institute, Brno) for the critical reading and English corrections. This work was supported by the EC (PathogenCombat No. FOOD-CT-2005-007081) and the Ministry of Agriculture of the Czech Republic (Grants Nos. MZe0002716201 and QH81065).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pribylova, R., Kralik, P. & Pavlik, I. Oligonucleotide Microarray Technology and its Application to Mycobacterium avium subsp. paratuberculosis Research: A Review. Mol Biotechnol 42, 30–40 (2009). https://doi.org/10.1007/s12033-008-9137-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12033-008-9137-5